Justin Mason is Professor of Vascular Rheumatology within Vascular Sciences, National Heart and Lung Institute at Hammersmith Hospital.
Professor Mason leads a basic science research group investigating molecular mechanisms involved in the regulation of vascular endothelial cytoprotection. A more detailed understanding of these mechanisms will facilitate the rational design of novel therapies by which vascular endothelium can be conditioned in order to minimise vascular injury, EC dysfunction and subsequent atherogenesis in patients with systemic inflammatory disease. In addition, he is actively involved in clinical research, which aims to optimise clinical assessment and treatment of the large vessel vasculitides and understand the relationship between chronic endothelial dysfunction and accelerated atherosclerosis. Read more on Justin's research.
Justin graduated in Medicine in 1986 from the University of London and trained in Rheumatology at the Kennedy Institute of Rheumatology, Charing Cross Hospital and at the Royal Postgraduate Medical School in London. Following award of a Medical Research Council Training Fellowship in 1992 and subsequently a PhD degree in 1996 from Imperial College London, he was awarded an Arthritis Research Campaign Senior Research Fellowship in 2000. He is a Fellow of the Royal College of Physicians in London and of the Association of Physicians of Great Britain and Ireland, and is the Chair of the Arthritis Research UK - Research Education and Capacity Committee, a member of the Medical Research Society Committee and the British Heart Foundation Project Grant Committee..
Tarkin JM, Mason JC, Fayad ZA, 2019, Imaging at the inter-face of inflammation and angiogenesis by 18F-fluciclatide PET., Heart
et al., 2019, Corrigendum: Giant cell arteritis: new concepts, treatments and the unmet need that remains, Rheumatology, Vol:58, ISSN:1462-0324, Pages:1123-1125
et al., 2019, IgG4-related disease in a multi-ethnic community: Clinical characteristics and association with malignancy, Qjm: an International Journal of Medicine, ISSN:1460-2393
et al., 2019, VERTEBRATE HEMATOMA RESOLUTION IS DIRECTED BY ACTIVATING TRANSCRIPTION FACTOR 1 (ATF1) AND ADENOSINE-MONOPHOSPHATE-ACTIVATED-PROTEIN-KINASE (AMPK), 87th Congress of the European-Atherosclerosis-Society (EAS), ELSEVIER IRELAND LTD, Pages:E246-E246, ISSN:0021-9150
et al., 2019, METFORMIN DIRECTLY SUPPRESSES ATHEROSCLEROSIS IN NORMOGLYCEMIC MICE VIA HAEMATOPOIETIC ADENOSINE MONOPHOSPHATE-ACTIVATED PROTEIN KINASE (AMPK), 87th Congress of the European-Atherosclerosis-Society (EAS), ELSEVIER IRELAND LTD, Pages:E45-E46, ISSN:0021-9150